Krishna Vaddi - Net Worth and Insider Trading
Krishna Vaddi Net Worth
The estimated net worth of Krishna Vaddi is at least $6 Million dollars as of 2024-04-30. Krishna Vaddi is the CEO of Prelude Therapeutics Inc and owns about 1,611,595 shares of Prelude Therapeutics Inc (PRLD) stock worth over $6 Million. Details can be seen in Krishna Vaddi's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Krishna Vaddi has not made any transactions after 2023-05-25 and currently still holds the listed stock(s).
Transaction Summary of Krishna Vaddi
Krishna Vaddi Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Krishna Vaddi owns 1 companies in total, including Prelude Therapeutics Inc (PRLD) .
Click here to see the complete history of Krishna Vaddi’s form 4 insider trades.
Insider Ownership Summary of Krishna Vaddi
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PRLD | Prelude Therapeutics Inc | 2023-05-25 | director & President & CEO |
Krishna Vaddi Latest Holdings Summary
Krishna Vaddi currently owns a total of 1 stock. Krishna Vaddi owns 1,611,595 shares of Prelude Therapeutics Inc (PRLD) as of May 25, 2023, with a value of $6 Million.
Latest Holdings of Krishna Vaddi
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PRLD | Prelude Therapeutics Inc | 2023-05-25 | 1,611,595 | 3.84 | 6,188,525 |
Holding Weightings of Krishna Vaddi
Krishna Vaddi Form 4 Trading Tracker
According to the SEC Form 4 filings, Krishna Vaddi has made a total of 3 transactions in Prelude Therapeutics Inc (PRLD) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Prelude Therapeutics Inc is the acquisition of 1,900 shares on May 25, 2023, which cost Krishna Vaddi around $9,785.
Insider Trading History of Krishna Vaddi
- 1
Krishna Vaddi Trading Performance
GuruFocus tracks the stock performance after each of Krishna Vaddi's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Krishna Vaddi is -10.02%. GuruFocus also compares Krishna Vaddi's trading performance to market benchmark return within the same time period. The performance of stocks bought by Krishna Vaddi within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Krishna Vaddi's insider trading performs compared to the benchmark.
Performance of Krishna Vaddi
Average Return
-20.28%
Outperforming Transactions
0%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.33 | -10.02 | -22.95 | -20.28 | ||
| Relative Return to S&P 500(%) | 2.8 | -15.54 | -34.48 | -43.22 |
Krishna Vaddi Ownership Network
Ownership Network List of Krishna Vaddi
Ownership Network Relation of Krishna Vaddi
Krishna Vaddi Owned Company Details
What does Prelude Therapeutics Inc do?
Who are the key executives at Prelude Therapeutics Inc?
Krishna Vaddi is the director & President & CEO of Prelude Therapeutics Inc. Other key executives at Prelude Therapeutics Inc include Chief Legal Counsel & Corp Sec. Bryant David Lim , Chief Financial Officer Laurent Chardonnet , and director & 10 percent owner David P Bonita .
Prelude Therapeutics Inc (PRLD) Insider Trades Summary
Over the past 18 months, Krishna Vaddi made 3 insider transaction in Prelude Therapeutics Inc (PRLD) with a net purchase of 32,944. Other recent insider transactions involving Prelude Therapeutics Inc (PRLD) include a net purchase of 15,000 shares made by Laurent Chardonnet , a net purchase of 869,565 shares made by David P Bonita , and a net purchase of 869,565 shares made by Orbimed Advisors Llc .
In summary, during the past 3 months, insiders sold 0 shares of Prelude Therapeutics Inc (PRLD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 13,280 shares of Prelude Therapeutics Inc (PRLD) were sold and 1,789,474 shares were bought by its insiders, resulting in a net purchase of 1,776,194 shares.
Prelude Therapeutics Inc (PRLD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Prelude Therapeutics Inc Insider Transactions
Krishna Vaddi Mailing Address
Above is the net worth, insider trading, and ownership report for Krishna Vaddi. You might contact Krishna Vaddi via mailing address: C/o Prelude Therapeutics Incorporated, 200 Powder Mill Road, Wilmington De 19803.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
